EFG
TMO icon

Embree Financial Group’s Thermo Fisher Scientific TMO Stock Holding History

Embree Financial Group’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-446
Closed -$222K – 222
2025
Q1 		$222K Buy
+446
New +$242K 0.04% 190

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Embree Financial Group's TMO Position: Q2 2025 in Review

Embree Financial Group sold out of Thermo Fisher Scientific (TMO) in Q2 2025, closing a stake of 446 shares — an estimated $222K sold.

Embree Financial Group first reported a position in TMO in Q1 2025 and held it in 1 quarter. The position peaked at $222K in Q1 2025. 2,454 funds tracked by Wall St. Rank hold TMO as of Q2 2025.

  • Embree Financial Group reported no remaining Thermo Fisher Scientific position as of Q2 2025 after selling out during the quarter.
  • Embree Financial Group sold 446 Thermo Fisher Scientific shares in Q2 2025, an estimated $222K.
  • Embree Financial Group first reported a position in Thermo Fisher Scientific in Q1 2025 and held it in 1 quarter.
  • Embree Financial Group's Thermo Fisher Scientific position peaked at $222K in Q1 2025.
  • 2,454 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2025.

Based on Embree Financial Group's 13F filing for Q2 2025, filed 16 Jul 2025.